| Literature DB >> 19067913 |
Petr Hubacek1, Petra Keslova, Renata Formankova, Pavel Pochop, Ondrej Cinek, Miroslav Zajac, Jana Lochmanova, Jan Stary, Petr Sedlacek.
Abstract
We report an 18-yr-old female patient with repeated CMV reactivations after HSCT treated by several pre-emptive courses of virostatic therapy. Seven months after HSCT, she developed CMV encephalitis/retinitis. Initial therapy with GCV and hyperimmune globulin failed, and later on GCV-resistant strain was detected. Continual increase of CMV DNA in peripheral blood led us to combined therapy with CDV and FCV, which was successful and free of severe renal toxicity. To our best knowledge, this is the first reported case of successful CMV treatment with a combination of CDV and FCV.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19067913 DOI: 10.1111/j.1399-3046.2008.01070.x
Source DB: PubMed Journal: Pediatr Transplant ISSN: 1397-3142